12 Errors to Avoid in Coding Skin Procedures

Total Page:16

File Type:pdf, Size:1020Kb

12 Errors to Avoid in Coding Skin Procedures Gary N. Fox, MD, and Laura A. McCann, CPC, CCS-P Errors to Avoid in 12 Coding Skin Procedures Using the correct codes can mean the difference between getting paid and getting audited. oding and billing for diagnosing and treat- must be full thickness, which means entirely through the ing skin lesions is rife with potential pitfalls reticular dermis to fat. For example, let’s say a lesion that could lead to delayed payments at best appears to be a 4 mm nodular basal cell carcinoma (BCC) and increased insurer scrutiny or investiga- or a nevus. An 8 mm punch is used to excise the vis- tion forC fraud at worst. Because skin procedure codes take ible portion of the lesion with apparent 2 mm margins into account the type of removal, the size and location of in all directions with the punch carried full thickness. the lesion, your intent, and pathologic results, document- The lesion has been excised. The excision code includes ing your service and selecting the right code can be confus- anesthesia and straightforward, simple closure. If the ing. This article explains how to avoid some of the most procedure required extensive undermining, a two-layer common mistakes in skin procedure coding and provides closure, and removal of excess skin, a separate code for a an encounter form that can help you to more rapidly and moderately complex closure should be used. accurately report skin-related diagnoses and associated pro- By contrast, a biopsy is a procedure that samples any- cedures (see the form on page 14). thing less than a full lesion, even if full thickness (“inci- sional” rather than “excisional”). For example, sampling a 1 cm suspected squamous cell carcinoma (SCC) at full thick- Know the difference between an ness into subcutaneous fat with a 4 mm punch instrument excision and a biopsy. 1 centrally should be coded as a biopsy. A biopsy code might An excision is a procedure intended to fully remove a also be used when sampling one or more of a group of lesion. The specimen should include the lesion and the lesions for diagnosis, even if these sample lesions are com- surgical margins. To qualify as an excision, the procedure pletely excised, or when taking samples of a dermatitis. ➤ Downloaded from the Family Practice Management Web site at www.aafp.org/fpm. Copyright © 2012 American Academy of Family Physicians. For the private,January/February noncommercial 2013 use| www.aafp.org/fpm of one individual | FAMILYuser of PRACTICE the Web MANAGEMENTsite. | 11 SERGE BLOCH SERGE All other rights reserved. Contact [email protected] for copyright questions and/or permission requests. WHEN A PATIENT ASKS FOR REMOVAL FOR COSMETIC REASONS, MEDICARE, MEDICAID, AND MOST OTHER INSURANCE PLANS DO NOT COVER THE SERVICE. Complete removal does not necessarily ogy laboratories include that information in mean that an excision code should be used. their reports. When the intent is to entirely remove the A re-excision is a procedure on any lesion pathology by anything less than a full thick- that has been previously biopsied or under- ness technique, a shave code may be appro- gone an initial excision by you or anyone else. priate, even if the pathology report confirms When billing for a re-excision, use the total complete removal of the lesion. For example, closed length of the excision to guide your trying to completely remove a nevus or sus- code selection. When a patient presents for pected melanoma via a “scoop” or “sauceriza- a scheduled re-excision, you should bill for tion” technique that extends into the deep the procedure but not the office visit, unless dermis and not the fat should be coded as a significant, separately identifiable services are shave removal, not an excision. provided, in which case you could submit a Excisions, biopsies, code for the evaluation and management ser- and shaves have vice with modifier 25. Don’t overbill for excisions or their own defini- If re-excision shows no residual malig- underbill for re-excisions. tions and uses. 2 nancy, you should still bill the malignant A primary excision should be billed based on lesion diagnosis codes, because that was the the largest diameter of the lesion plus the nar- purpose of the re-excision. rowest lateral margins. For example, a round Measure lesions 4 mm lesion placed centrally in an 8 mm before removal Know the difference between punch has a lesion diameter of 4 mm and as they tend to 3 biopsy and shave. change shape 2 mm margins all around. The excision length afterward. for this lesion is 8 mm: 4 mm (lesion) plus When there is a dermatitis, such as suspected 2 mm (one narrowest margin) plus 2 mm psoriasis, contact dermatitis, or Grover’s (other narrowest margin). For an ovoid lesion disease, specimens you obtain for pathology measuring 8 mm by 4 mm, removed with 2 should be classified as biopsies even if the sam- Re-excisions don’t mm margins across the short diameter and pled lesions are entirely removed using a shave generate an added greater margins at the apices to fashion a fusi- technique. List your suspected diagnosis in office visit fee. form excision closer to the traditional length- your clinical notes, but you should bill using to-width ratio of 3:1, the calculation would be diagnosis code 709.9 for unspecified disorder 12 mm: 8 mm (lesion) plus 2 mm (narrowest of skin and subcutaneous tissue. If you use margins counted twice) (see the photo illustra- the code for psoriasis, for example, the insurer tion on the next page). may reject the claim and ask why you did a The lesion should be measured preopera- biopsy if you already knew the diagnosis. tively because tissue tends to change shape or If you remove and “cure” a symptomatic shrink in formalin, which causes pathologic seborrheic keratosis via a shave technique, measurement to be generally smaller than the that can be appropriately billed as a shave. If clinical measurement, and some dermapathol- you cannot determine whether a lesion is a seborrheic keratosis or a melanoma and you do a full thickness excision because of concern About the Authors about melanoma, it is legitimate to bill for Dr. Fox is a family physician who has limited his excision. It is almost always inappropriate to practice exclusively to skin diagnosis and treatment excise seborrheic keratoses when you are cer- since 2005 at the Mercy Defiance Clinic in Defiance, tain of the diagnosis. It is often appropriate to Ohio. Laura McCann is the information services remove them because of symptoms, but only director at Mercy Defiance Clinic. Author disclo- via the shave technique. Note that for smaller sure: no relevant financial affiliations disclosed. lesions, biopsy codes may provide greater 12 | FAMILY PRACTICE MANAGEMENT | www.aafp.org/fpm | January/February 2013 SKIN PROCEDURES reimbursement than shave codes. mend switching. I have used 238.2 exclusively Lines can be blurred. For example, let’s say for years with good results. a person has a single papulosquamous plaque, and the differential diagnosis includes SCC Don’t upcode destruction of and superficial BCC. An attempt to com- benign lesions or undercode pletely remove the lesion via a shave technique 4 destruction of malignancies. is documented. The histology report indicates Some procedures psoriasis. Because the intent was to evaluate Molluscum and verrucae are epidermal could be billed as biopsies or shaves, for a suspected malignancy and the lesion was lesions. On palms and soles, verrucae can be but the reimburse- completely removed, documentation would very deep and invaginate the epidermis and ment levels are support billing a shave code. A biopsy code even make radiographic impressions on bone. different for each. also would have been appropriate, but the However, even if you inject anesthesia and shave code is legitimate and the reimburse- curette a deep wart on a plantar surface or ment is greater. It is okay to get paid for what use any of a variety of methods of removing you do! molluscum, the appropriate code is either Wart removal is My research suggests that most derma- 17110 (destruction of benign lesions, 14 or most appropri- tologists tend to use the diagnosis code for fewer lesions) or 17111 (15 or more lesions), ately billed using neoplasm of uncertain behavior of skin because the billing should be based on what is destruction codes. (238.2) when biopsying or shaving a lesion of medically necessary. uncertain etiology because of concern about When dealing with a malignancy that is malignancy and billing before the histopathol- curable by cryotherapy alone or by curet- ogy is known. This remains the appropriate tage with or without electrodessication or Bill excisions based code after histology has returned for dysplas- cryotherapy, the procedure often starts with on adding their largest diameter tic nevi, sebaceous nevi, and other lesions of a shave followed by the destructive proce- with their narrowest uncertain biologic behavior. The other option dure. You can only bill for one procedure lateral margins. is to submit the diagnosis code for neoplasm in this case, and the codes for destruction of of uncertain nature (239.2). Some coding malignancies pay more than those for shaves authorities emphatically recommend this code or biopsies. For example, Medicare’s median rather than 238.2, but if you have been using nongeographically adjusted payment rate 238.2 without difficulty I wouldn’t recom- for destroying a 2.5 cm scalp lesion (code HOW TO MEASURE AN EXCISION LENGTH FOR PROPER CODING This macular lesion is suspicious for melanoma. Many authorities recommend a 2 mm margin, full thickness, primary excision for diagnosis and initial pathologic staging to guide subse- quent re-excision and management.
Recommended publications
  • Another Rashmanaging ? Common Skin Problems in Primary Care: Ugh….Another Rash Kathleen Haycraft, DNP, FNP/PNP-BC, DCNP, FAANP Objectives
    Another RashManaging ? Common Skin Problems in Primary Care: Ugh….Another Rash Kathleen Haycraft, DNP, FNP/PNP-BC, DCNP, FAANP Objectives At the completion of this session the learner will be able to: 1. Identify common skin rashes seen in dermatology 2. Differentiate between rashes that require urgent treatment and those that require monitored therapy. 3. Determine an appropriate treatment plan for common rashes Financial Disclosures and COI The speaker is on the advisory committee for: ABVIE CELGENE LILLY NOVARTIS PFIZER VALEANT Significance Dermatologic conditions are the number one reason to enter ambulatory walk in clinics The skin it the largest organ of the body and frequently is a measure of what is occurring internally Take a good history Duration What did it look like in the beginning and how has it progressed? Does anyone else in your immediate family or workers have a similar rash? Have you been ill and in what way? What have you treated the rash with prescription or over the counter medications? Take a good history Have they seen anyone and what diagnosis where you given? What is your medical history? What medicines do you take? Does it itch, hurt, scale, or asymptomatic? Give it a scale. How did it begin and what does has it changed (tie this into treatment history)? Is the patient sick? What does it looks like? Macule vs. Patch Papule, nodule, pustule, tumor Vesicle or Bulla Petechial or purpura Indurated vs. non-indurated Is it crusted…deep or superficial What pattern…. Blaschkos vs. dermatome,, symmetrical, central vs. caudal, reticular, annular vs.
    [Show full text]
  • Multiple Asymptomatic Papules on the Back of the Right Side of the Chest Angoori Gnaneshwar Rao
    QUIZ Multiple Asymptomatic Papules on the Back of the Right Side of the Chest Angoori Gnaneshwar Rao A 43-year-old male presented with multiple asymptomatic complete blood picture, blood sugar, complete urine examination, papules on the back of the right side of the chest of 1 year blood urea, serum creatinine, liver function tests and serum duration. He was asymptomatic a year back then he developed lipid profile were normal. Fundus was normal. A slit skin smear small papules on the right side of the front of the chest initially for acid fast bacilli was negative. A punch biopsy from the and later on involved the front and back of the chest. No representative lesion subjected to histopathological examination history was suggestive of leprosy and hyperlipidemias. Family revealed a cyst with an intricately folded wall, lined by two to history was negative for similar problem. Examination revealed three layers of flattened squamous epithelium and the absence multiple skin-colored to yellowish papules distributed on the of the granular layer. Lobules of sebaceous glands were found front and back of the chest and shoulder region on the right embedded in cyst lining. The lumen was filled with amorphous side [Figure 1]. Also, there were multiple hyperpigmented eosinophilic material and multiple hair shafts [Figures 2-4]. macules on the right infrascapular region. There was no nerve thickening and no sensory deficit and there were no Question hypopigmented or anesthetic patches. Systemic examination did not reveal any abnormality. Routine investigations including What is your diagnosis? (Original) Multiple skin-colored to yellowish papules on the back of chest Figure 1: Figure 2: (Original) Histopathology of skin showing a cyst with an intricately folded and shoulder region on the right side wall lined by two to three layers of flattened squamous epithelium and the absence of granular layer.
    [Show full text]
  • Skin Lesions in Diabetic Patients
    Rev Saúde Pública 2005;39(4) 1 www.fsp.usp.br/rsp Skin lesions in diabetic patients N T Foss, D P Polon, M H Takada, M C Foss-Freitas and M C Foss Departamento de Clínica Médica. Faculdade de Medicina de Ribeirão Preto. Universidade de São Paulo. Ribeirão Preto, SP, Brasil Keywords Abstract Skin diseases. Dermatomycoses. Diabetes mellitus. Metabolic control. Objective It is yet unknown the relationship between diabetes and determinants or triggering factors of skin lesions in diabetic patients. The purpose of the present study was to investigate the presence of unreported skin lesions in diabetic patients and their relationship with metabolic control of diabetes. Methods A total of 403 diabetic patients, 31% type 1 and 69% type 2, underwent dermatological examination in an outpatient clinic of a university hospital. The endocrine-metabolic evaluation was carried out by an endocrinologist followed by the dermatological evaluation by a dermatologist. The metabolic control of 136 patients was evaluated using glycated hemoglobin. Results High number of dermophytosis (82.6%) followed by different types of skin lesions such as acne and actinic degeneration (66.7%), pyoderma (5%), cutaneous tumors (3%) and necrobiosis lipoidic (1%) were found. Among the most common skin lesions in diabetic patients, confirmed by histopathology, there were seen necrobiosis lipoidic (2 cases, 0.4%), diabetic dermopathy (5 cases, 1.2%) and foot ulcerations (3 cases, 0.7%). Glycated hemoglobin was 7.2% in both type 1 and 2 patients with adequate metabolic control and 11.9% and 12.7% in type 1 and 2 diabetic patients, respectively, with inadequate metabolic controls.
    [Show full text]
  • Metastasis of Meningioma: a Rare Differential Diagnosis In
    logy: Op go en n y A Lunger et al., Otolaryngol (Sunnyvale) 2017, 7:6 r c a c l e o s t DOI: 10.4172/2161-119X.1000333 s O Otolaryngology: Open Access ISSN: 2161-119X Case Report OpenOpen Access Access Metastasis of Meningioma: A Rare Differential Diagnosis in Subcutaneous Masses of the Scalp Alexander Lunger1*, Tarek Ismail1#, Adrian Dalbert2, Kirsten Mertz3, Thomas Weikert4, Dirk Johannes Schaefer1 and Ilario Fulco1 1Department of Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital Basel, Basel, Switzerland 2Department of Otorhinolaryngology-Head and Neck Surgery, University Hospital Zurich, Zurich, Switzerland 3Department of Pathology, Kantonsspital Basel Land, Liestal, Switzerland 4Department of Radiology, University Hospital Basel, Switzerland Abstract Background: Subcutaneous masses of the scalp have a wide range of differential diagnosis. After removal of a meningioma in the patient’s history, scalp metastasis from the previously resected meningioma should be considered. Methods: A 86 year old patient presented with a local swelling on the left temporal forehead and no other clinical symptoms. Eleven years earlier an extra-axial meningioma was resected. The patient was receiving immunosuppressive therapy subsequent to kidney transplantation. After clinical examination and MRI, a lipoma was suspected. The mass was resected under local anesthesia. Results: Histopathology revealed a metastasis of the previously removed meningioma (WHO grade II). No further treatment was recommended. Clinical follow-up was without pathological findings so far. Conclusion: Scalp metastases of meningiomas are a rare finding. However, if patient history reveals removal of a meningioma, scalp metastasis must be a differential diagnosis for subcutaneous masses even years after the initial surgery.
    [Show full text]
  • Training Available: in 2012, Lorenzo Kunze, M.E
    2013 Derma-Lo - offers the 2013 Thermo-Lo - offers the reduction of: sun/age spot, milia, reduction of: sun/age spot, milia, telangiectasia / epidermal spider telangiectasia / epidermal spider veins, cherry hemangiomas, veins, cherry hemangiomas and Thermolysis (AC) and Electrolysis Thermolysis (AC) hair removal. (DC) hair removal. Also: active acne, acne scarring, sebaceous hyperplasia, and skin tags. Training Available: In 2012, Lorenzo Kunze, M.E. Includes: Hydro-Lo - treatment IN DENVER ONCE A MONTH developed Chromos, Inc. - which of fine lines and wrinkles, TRAINING AVAILABLE AT in Greek, can be interpreted as enlarged pore reduction, boosts YOUR LOCATION ASK ABOUT “color” or “light” – in essence, the penetration of product into COST without light we have no color. the skin and tightens loose skin. “Dedicated to Excellence” Also: select your choice of (1 of Continuing to provide a professional & positive attitude in the medical 2) LED’s – both are non invasive and aesthetic field. hand-held light probes: BLUE for CHROMOS, Inc. the treatment of acne or Lorenzo Kunze, M.E. Chromos strives to be a guiding INFRARED to increase collagen [email protected] “light” that assists medical and and elastin, Rosacea, increased www.DermaLo.com aesthetic professionals in finding healing properties, minor muscle www.Thermo-Lo.com and pursuing proper education and moderate joint pain. 888-499-8991 / 303-994-7236 and accurate knowledge. Lorenzo Kunze, M.E. Lorenzo is a true visionary - 40 years in the medical and aesthetic field Medical Electrologist / medical educator 1st non-medical professional to provide electrolysis treatments in an OR Treated over 20,000 patients - last 16 years 1st in the U.S.
    [Show full text]
  • Dermatology DDX Deck, 2Nd Edition 65
    63. Herpes simplex (cold sores, fever blisters) PREMALIGNANT AND MALIGNANT NON- 64. Varicella (chicken pox) MELANOMA SKIN TUMORS Dermatology DDX Deck, 2nd Edition 65. Herpes zoster (shingles) 126. Basal cell carcinoma 66. Hand, foot, and mouth disease 127. Actinic keratosis TOPICAL THERAPY 128. Squamous cell carcinoma 1. Basic principles of treatment FUNGAL INFECTIONS 129. Bowen disease 2. Topical corticosteroids 67. Candidiasis (moniliasis) 130. Leukoplakia 68. Candidal balanitis 131. Cutaneous T-cell lymphoma ECZEMA 69. Candidiasis (diaper dermatitis) 132. Paget disease of the breast 3. Acute eczematous inflammation 70. Candidiasis of large skin folds (candidal 133. Extramammary Paget disease 4. Rhus dermatitis (poison ivy, poison oak, intertrigo) 134. Cutaneous metastasis poison sumac) 71. Tinea versicolor 5. Subacute eczematous inflammation 72. Tinea of the nails NEVI AND MALIGNANT MELANOMA 6. Chronic eczematous inflammation 73. Angular cheilitis 135. Nevi, melanocytic nevi, moles 7. Lichen simplex chronicus 74. Cutaneous fungal infections (tinea) 136. Atypical mole syndrome (dysplastic nevus 8. Hand eczema 75. Tinea of the foot syndrome) 9. Asteatotic eczema 76. Tinea of the groin 137. Malignant melanoma, lentigo maligna 10. Chapped, fissured feet 77. Tinea of the body 138. Melanoma mimics 11. Allergic contact dermatitis 78. Tinea of the hand 139. Congenital melanocytic nevi 12. Irritant contact dermatitis 79. Tinea incognito 13. Fingertip eczema 80. Tinea of the scalp VASCULAR TUMORS AND MALFORMATIONS 14. Keratolysis exfoliativa 81. Tinea of the beard 140. Hemangiomas of infancy 15. Nummular eczema 141. Vascular malformations 16. Pompholyx EXANTHEMS AND DRUG REACTIONS 142. Cherry angioma 17. Prurigo nodularis 82. Non-specific viral rash 143. Angiokeratoma 18. Stasis dermatitis 83.
    [Show full text]
  • Interstitial Granuloma Annulare Triggered by Lyme Disease
    Volume 27 Number 5| May 2021 Dermatology Online Journal || Case Presentation 27(5):11 Interstitial granuloma annulare triggered by Lyme disease Jordan Hyde1 MD, Jose A Plaza1,2 MD, Jessica Kaffenberger1 MD Affiliations: 1Division of Dermatology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA, 2Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA Corresponding Author: Jessica Kaffenberger MD, Division of Dermatology, The Ohio State University Medical Wexner Medical Center, Suite 240, 540 Officenter Place, Columbus, OH 43230, Tel: 614-293-1707, Email: [email protected] been associated with a variety of systemic diseases Abstract including diabetes mellitus, malignancy, thyroid Granuloma annulare is a non-infectious disease, dyslipidemia, and infection [3,4]. granulomatous skin condition with multiple different associations. We present a case of a man in his 60s There are multiple histological variants of GA, with a three-week history of progressive targetoid including interstitial GA. The histopathology of plaques on his arms, legs, and trunk. Skin biopsy classic GA demonstrates a focal degeneration of demonstrated interstitial granuloma annulare. collagen surrounded by an inflammatory infiltrate Additional testing revealed IgM antibodies to Borrelia composed of lymphocytes and histiocytes. In a less burgdorferi on western blot suggesting interstitial common variant, interstitial GA, scattered histiocytes granuloma annulare was precipitated by the recent are seen
    [Show full text]
  • A Review of the Evidence for and Against a Role for Mast Cells in Cutaneous Scarring and Fibrosis
    International Journal of Molecular Sciences Review A Review of the Evidence for and against a Role for Mast Cells in Cutaneous Scarring and Fibrosis Traci A. Wilgus 1,*, Sara Ud-Din 2 and Ardeshir Bayat 2,3 1 Department of Pathology, Ohio State University, Columbus, OH 43210, USA 2 Centre for Dermatology Research, NIHR Manchester Biomedical Research Centre, Plastic and Reconstructive Surgery Research, University of Manchester, Manchester M13 9PT, UK; [email protected] (S.U.-D.); [email protected] (A.B.) 3 MRC-SA Wound Healing Unit, Division of Dermatology, University of Cape Town, Observatory, Cape Town 7945, South Africa * Correspondence: [email protected]; Tel.: +1-614-366-8526 Received: 1 October 2020; Accepted: 12 December 2020; Published: 18 December 2020 Abstract: Scars are generated in mature skin as a result of the normal repair process, but the replacement of normal tissue with scar tissue can lead to biomechanical and functional deficiencies in the skin as well as psychological and social issues for patients that negatively affect quality of life. Abnormal scars, such as hypertrophic scars and keloids, and cutaneous fibrosis that develops in diseases such as systemic sclerosis and graft-versus-host disease can be even more challenging for patients. There is a large body of literature suggesting that inflammation promotes the deposition of scar tissue by fibroblasts. Mast cells represent one inflammatory cell type in particular that has been implicated in skin scarring and fibrosis. Most published studies in this area support a pro-fibrotic role for mast cells in the skin, as many mast cell-derived mediators stimulate fibroblast activity and studies generally indicate higher numbers of mast cells and/or mast cell activation in scars and fibrotic skin.
    [Show full text]
  • 2017 Oregon Dental Conference® Course Handout
    2017 Oregon Dental Conference® Course Handout Nasser Said-Al-Naief, DDS, MS Course 8125: “The Mouth as The Body’s Mirror: Oral, Maxillofacial, and Head and Neck Manifestations of Systemic Disease” Thursday, April 6 2 pm - 3:30 pm 2/28/2017 The Mouth as The Body’s Mirror Oral Maxillofacial and Head and Neck Manifestation of Ulcerative Conditions of Allergic & Immunological Systemic Disease the Oro-Maxillofacial Diseases Region Nasser Said-Al-Naief, DDS, MS Professor & Chair, Oral Pathology and Radiology Director, OMFP Laboratory Oral manifestations of Office 503-494-8904// Direct: 503-494-0041 systemic diseases Oral Manifestations of Fax: 503-494-8905 Dermatological Diseases Cell: 1-205-215-5699 Common Oral [email protected] Conditions [email protected] OHSU School of Dentistry OHSU School of Medicine 2730 SW Moody Ave, CLSB 5N008 Portland, Oregon 97201 Recurrent aphthous stomatitis (RAS) Recurrent aphthous stomatitis (RAS) • Aphthous" comes from the Greek word "aphtha”- • Recurrence of one or more painful oral ulcers, in periods of days months. = ulcer • Usually begins in childhood or adolescence, • The most common oral mucosal disease in North • May decrease in frequency and severity by age America. (30+). • Affect 5% to 66% of the North American • Ulcers are confined to the lining (non-keratinized) population. mucosa: • * 60% of those affected are members of the • Buccal/labial mucosa, lateral/ventral tongue/floor of professional class. the mouth, soft palate/oropharyngeal mucosa • Etiopathogenesis: 1 2/28/2017 Etiology of RAU Recurrent Aphthous Stomatitis (RAS): Types: Minor; small size, shallow, regular, preceeded by prodrome, heal in 7-10 days Bacteria ( S.
    [Show full text]
  • Rosacea: an Update
    REVIEW JONELLE K. MCDONNELL, MD KENNETH J. TOMECKI, MD Department of Dermatology, Cleveland Clinic Department of Dermatology, Cleveland Clinic Rosacea: An update • ABSTRACT | >1 OSACEA is a chronic and recurrent LAM inflammatory skin disease characterized Rosacea is a common inflammatory skin disease affecting by erythema, papules, pustules, telangiectasia, the central face of adults. Its etiology is unknown. Early and occasionally sebaceous hyperplasia, which diagnosis and appropriate treatment, usually with topical or primarily affects the central face. The disease systemic antibiotics or both, minimizes symptoms and helps evolves in stages and affects middle-aged to prevent complications. adults. Early diagnosis and thoughtful manage- ment help to control the disease and to mini- • KEY POINTS mize the patient's discomfort and emotional distress. Historically, rosacea has been a mis- Rosacea has a spectrum of cutaneous clinical findings: understood disorder, often attributed to alco- facial erythema, papules, pustules, telangiectasia, and holism and acne.1 rhinophyma. • INCIDENCE Common triggers are sunlight, stress, exposure to extreme Rosacea is a common and chronic disease that heat or cold, alcohol, hot beverages, and spicy foods. affects approximately 13 million Americans, or about 1 in 20 people. Because rosacea fre- Rosacea can resemble other diseases, including acne, quently affects people of northern European seborrheic dermatitis, systemic lupus erythematosus, and heritage, it is often called the "curse of the sarcoidosis. Celts."2 In contrast, it is rarely seen in dark- skinned individuals.3 In most patients, the Ocular involvement occurs in more than 50% of patients onset occurs between the ages of 30 and 50. with rosacea. The early stages affect women more often than men at a ratio of 3 to 1, but men more often Oral tetracycline and topical metronidazole are the develop disfiguring rhinophyma.
    [Show full text]
  • Topical Treatments for Seborrheic Keratosis: a Systematic Review
    SYSTEMATIC REVIEW AND META-ANALYSIS Topical Treatments for Seborrheic Keratosis: A Systematic Review Ma. Celina Cephyr C. Gonzalez, Veronica Marie E. Ramos and Cynthia P. Ciriaco-Tan Department of Dermatology, College of Medicine and Philippine General Hospital, University of the Philippines Manila ABSTRACT Background. Seborrheic keratosis is a benign skin tumor removed through electrodessication, cryotherapy, or surgery. Alternative options may be beneficial to patients with contraindications to standard treatment, or those who prefer a non-invasive approach. Objectives. To determine the effectiveness and safety of topical medications on seborrheic keratosis in the clearance of lesions, compared to placebo or standard therapy. Methods. Studies involving seborrheic keratosis treated with any topical medication, compared to cryotherapy, electrodessication or placebo were obtained from MEDLINE, HERDIN, and Cochrane electronic databases from 1990 to June 2018. Results. The search strategy yielded sixty articles. Nine publications (two randomized controlled trials, two non- randomized controlled trials, three cohort studies, two case reports) covering twelve medications (hydrogen peroxide, tacalcitol, calcipotriol, maxacalcitol, ammonium lactate, tazarotene, imiquimod, trichloroacetic acid, urea, nitric-zinc oxide, potassium dobesilate, 5-fluorouracil) were identified. The analysis showed that hydrogen peroxide 40% presented the highest level of evidence and was significantly more effective in the clearance of lesions compared to placebo. Conclusion. Most of the treatments reviewed resulted in good to excellent lesion clearance, with a few well- tolerated minor adverse events. Topical therapy is a viable option; however, the level of evidence is low. Standard invasive therapy remains to be the more acceptable modality. Key Words: seborrheic keratosis, topical, systematic review INTRODUCTION Description of the condition Seborrheic keratoses (SK) are very common benign tumors of the hair-bearing skin, typically seen in the elderly population.
    [Show full text]
  • A Patient with Plaque Type Morphea Mimicking Systemic Lupus Erythematosus
    CASE REPORT A Patient With Plaque Type Morphea Mimicking Systemic Lupus Erythematosus Wardhana1, EA Datau2 1 Department of Internal Medicine, Siloam International Hospitals. Karawaci, Indonesia. 2 Department of Internal Medicine, Prof. Dr. RD Kandou General Hospital & Sitti Maryam Islamic Hospital, Manado, North Sulawesi, Indonesia. Correspondence mail: Siloam Hospitals Group’s CEO Office, Siloam Hospital Lippo Village. 5th floor. Jl. Siloam No.6, Karawaci, Indonesia. email: [email protected] ABSTRAK Morfea merupakan penyakit jaringan penyambung yang jarang dengan gambaran utama berupa penebalan dermis tanpa disertai keterlibatan organ dalam. Penyakit ini juga dikenal sebagai bagian dari skleroderma terlokalisir. Berdasarkan gambaran klinis dan kedalaman jaringan yang terlibat, morfea dikelompokkan ke dalam beberapa bentuk dan sekitar dua pertiga orang dewasa dengan morfea mempunyai tipe plak. Produksi kolagen yang berlebihan oleh fibroblast merupakan penyebab kelainan pada morfea dan mekanisme terjadinya aktivitas fibroblast yang berlebihan ini masih belum diketahui, meskipun beberapa mekanisme pernah diajukan. Morfe tipe plak biasanya bersifat ringan dan dapat sembuh dengan sendirinya. Morfea tipe plak yang penampilan klinisnya menyerupai lupus eritematosus sistemik, misalnya meliputi alopesia dan ulkus mukosa di mulut, jarang dijumpai. Sebuah kasus morfea tipe plak pada wanita berusia 20 tahun dibahas. Pasien ini diobati dengan imunosupresan dan antioksidan local maupun sistemik. Kondisi paisen membaik tanpa disertai efek samping yang berarti. Kata kunci: morfea, tipe plak. ABSTRACT Morphea is an uncommon connective tissue disease with the most prominent feature being thickening or fibrosis of the dermal without internal organ involvement. It is also known as a part of localized scleroderma. Based on clinical presentation and depth of tissue involvement, morphea is classified into several forms, and about two thirds of adults with morphea have plaque type.
    [Show full text]